Company Overview

Stryker Corporation is a global medical technology company that designs, manufactures, and markets a broad range of medical devices and equipment used primarily in orthopaedics, medical and surgical care, and neurotechnology and spine. The company serves hospitals, ambulatory surgery centers, physicians, and other healthcare providers, with revenue driven largely by procedure volumes, capital equipment sales, and recurring disposable products. Stryker is recognized for its strong innovation pipeline, premium product positioning, and deep integration into clinical workflows.

Founded in 1941 by orthopaedic surgeon Homer Stryker, the company began with orthopaedic innovations and gradually expanded through internal development and acquisitions. Over decades, Stryker evolved into one of the world’s largest medical device manufacturers by broadening its portfolio across surgical equipment, implants, and digital healthcare technologies, while maintaining a focus on high-growth, procedure-driven markets.

Business Operations

Stryker operates through three primary business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment includes joint replacement implants, trauma and extremities products, and biologics, generating revenue through implant sales and related instruments. The MedSurg segment encompasses surgical equipment, endoscopy systems, patient handling, and emergency medical products, combining capital equipment with recurring consumables. The Neurotechnology and Spine segment focuses on neurovascular devices, cranial and spinal implants, and minimally invasive technologies used in complex neurological procedures.

The company generates revenue globally through direct sales forces in major markets and distributor relationships in select regions. Stryker controls proprietary manufacturing facilities, R&D centers, and digital platforms that support connected operating rooms and data-driven healthcare solutions. Key subsidiaries include MAKO Surgical, which underpins Stryker’s robotic-assisted surgery platform, and Physio-Control, a leading provider of emergency medical response equipment.

Strategic Position & Investments

Stryker’s strategic direction emphasizes innovation, operational excellence, and disciplined acquisitions in high-growth medical technology categories. Growth initiatives include expanding robotic-assisted surgery through the MAKO platform, increasing penetration of single-use and disposable products, and advancing digital and data-enabled healthcare solutions. The company consistently invests in R&D to enhance minimally invasive procedures and improve clinical outcomes.

Stryker has a long history of acquisitions to strengthen its portfolio and enter adjacent markets. Notable acquisitions include Wright Medical Group to expand extremities and biologics, Vocera Communications to enhance digital healthcare communication, and Cerus Endovascular to strengthen neurovascular offerings. These investments align with Stryker’s focus on higher-growth, higher-margin segments and long-term procedure volume expansion.

Geographic Footprint

Stryker is headquartered in North America, with its corporate headquarters in Kalamazoo, Michigan, and operates in more than 75 countries worldwide. The company has a significant presence across North America, Europe, Asia-Pacific, and Latin America, supported by regional manufacturing, distribution, and research facilities. The United States remains its largest single market, accounting for the majority of revenue.

International operations play a critical role in Stryker’s growth strategy, particularly in developed healthcare markets in Western Europe and fast-growing markets in Asia-Pacific. The company continues to expand its international footprint through direct sales expansion, localized manufacturing, and targeted investments to increase access to advanced medical technologies globally.

Leadership & Governance

Stryker is led by an experienced executive team with a strategic focus on innovation, customer partnership, and sustainable growth. The leadership philosophy emphasizes long-term value creation, ethical governance, and investment in people and technology to support clinicians and improve patient outcomes. The company operates under a strong corporate governance framework aligned with public company and regulatory standards.

Key executives include:

• Kevin A. Lobo – Chairman and Chief Executive Officer
• Glenn S. Boehnlein – Chief Financial Officer
• Viju Menon – President, Global Quality and Operations
• Andy Pierce – Group President, MedSurg and Neurotechnology
• Bartley J. Doyle – Group President, Orthopaedics
• Katherine Owen – Chief Corporate Affairs Officer and Secretary

The leadership team collectively drives Stryker’s strategic execution, global expansion, and continued focus on innovation and operational discipline.